12.05.2016 • News

Kullmann appointed Deputy Chairman of the Executive Board of Evonik

The Supervisory Board of Evonik appointed Christian Kullmann (47) Deputy Chairman of the Executive Board with immediate effect. Kullmann has been on the Executive Board since July 2014 and has the role of chief strategic officer. He joined the company in 2003.

Klaus Engel, Chairman of the Executive Board, compliments Kullmann, who could become his designated successor: “I highly recommended Christian Kullmann as a Board Member at the time, and I now recommend him equally highly as my deputy. He stands for continuity and dependability towards employees, customers and investors. We will continue along our successful path in the same spirit of trusting cooperation.”

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read